Ribo partners with Boehringer Ingelheim to develop new treatments for people with liver diseases
Ribo's cutting edge RIBO-GalSTAR platform enables the development of RNAi therapeutics targeting disease-causing genes specifically in hepatocytes
Ribo's cutting edge RIBO-GalSTAR platform enables the development of RNAi therapeutics targeting disease-causing genes specifically in hepatocytes
H.C. Wainwright & Co. acted as the exclusive placement agent for the offering
Elpiscience will receive up to US $37 million, including the upfront payment and license option fees
MedTech Mitra is a platform that will help the young talents of the country by holding their hands and giving them final shape to their research, knowledge and logic
The LyondellBasell CirculenRenew polymers are made from renewable feedstocks derived from bio-based wastes
Funding round led by Sarissa Capital, includes Sun Pharma, Polaris Partners
Employer-sponsored health insurance costs in India are expected to rise by 11% in 2024
The bioprocess business will continue to pioneer contributions to safety and productivity in the manufacture of biotherapeutics
Biocon Biologics is one among the three pharmaceutical companies from India to be featured on this year's list
The product will be manufactured at Lupin's Pithampur facility in India
Subscribe To Our Newsletter & Stay Updated